Following an investigational new drug application clearance from the FDA, a phase 1 trial plans to evaluate CD-001.

The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...

A D.C. drugmaker has been dealt a major setback in its long-running bid to bring its treatment for a chronic gastrointestinal ...

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

The market for weight-loss treatments is expected to see 16 new drugs vying for a slice of the lucrative business currently ...

A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Timely toxicology material delivery is crucial for IND and CTA approvals, helping to advance drug candidates efficiently to ...

Newcells Biotech (“Newcells”), a leading drug discovery partner specialising in the development of in vitro models and ...

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) ...

Graphene-based nanomaterials show promise in drug delivery, but challenges like toxicity and aggregation must be addressed ...

On World Alzheimer's Day, we examine how a timely diagnosis can prepare someone with early dementia, and the pros and cons of ...